Beam Therapeutics Inc.

NASDAQ:BEAM

Biotechnology

Healthcare
$20.94 +1.46%

+$0.48 today

Market cap
$2.17B
Beta
2.20
P/E (TTM)
-52.3
EPS (TTM)
-$0.63
52W Low $15.60High $36.44

Volume 4.21M

Average 2.11M

Price history

Beam Therapeutics Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-0.19%

Period high

$37.92

Period low

$20.60

Latest

$20.94

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13G/ANov 13, 2026Nov 13, 2026
8-KNov 3, 2026Nov 3, 2026
10-QNov 3, 2026Nov 3, 2026
4Oct 16, 2026Oct 16, 2026
4Oct 2, 2026Oct 2, 2026
4Sep 25, 2026Sep 25, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13G/AAug 13, 2026Aug 13, 2026
8-KAug 4, 2026Aug 4, 2026
10-QAug 4, 2026Aug 4, 2026
4Jul 29, 2026Jul 29, 2026
4Jul 2, 2026Jul 2, 2026
4Jul 1, 2026Jul 1, 2026
4Jun 29, 2026Jun 29, 2026
4Jun 22, 2026Jun 22, 2026

Competitors

Who does Beam Therapeutics Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about BEAM's filings, answered from its disclosures.

What is the latest BEAM filing?

The latest filing shown is SC 13G/A dated Nov 13, 2026.

How many recent filings does BEAM have?

Intrinsic Alpha currently shows 20 recent filings for BEAM.